Article
Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows
25 Oct 2019
Abstract excerpt
Parkinson’s disease (PD) is a neurodegenerative disorder that currently affects 1% of the population over the age of 60 years, for which no disease-modifying treatments exist. This lack of effective treatments is related to the advanced stage of neurodegeneration existing at the time of diagnosis. Thus, the identification of early stage biomarkers is crucial. Biomarker discovery is often guided by the underlying...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
